INS and Alzheimer disease: Epidemiological and clinical studies have overwhelmingly confirmed that defective insulin signaling in the brain plays a central role in the early stages of dementia, a primary feature of sporadic Alzheimer’s disease (AD) and AD- Related Dementias (ADRD) pathology1–9.